| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/14/2010 | WO2010005572A2 Alpha-keto heterocycles as faah inhibitors |
| 01/14/2010 | WO2010005513A2 Crystal structure of staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 01/14/2010 | WO2010005403A1 Dermatological composition for use in the treatment and/or prevention of skin diseases |
| 01/14/2010 | WO2010005378A1 Antimicrobial composition |
| 01/14/2010 | WO2010005344A1 Nanosomal pharmaceutical form of a long acting preparation for treating hepatitis c (variants) |
| 01/14/2010 | WO2010005012A1 Apolactoferrin-containing composition |
| 01/14/2010 | WO2010005010A1 Anti-influenza virus agent, anti-rs virus agent, and anti-immunodeficiency virus agent |
| 01/14/2010 | WO2010004653A1 Eradicating agent and eradication method for helicobacter pylori |
| 01/14/2010 | WO2010004525A1 Compositions containing a combination of propolis and a phenolic derivative and biological applications thereof |
| 01/14/2010 | WO2010004394A1 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 01/14/2010 | WO2010004231A2 Novel compounds, use thereof as medicaments, and method for the preparation thereof |
| 01/14/2010 | WO2010003658A1 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 01/14/2010 | WO2010003369A1 Cyclin-dependent kinases inhibitor of baicalin organic amine derivatives, synthesis and use thereof |
| 01/14/2010 | WO2010003319A1 Hydrates of erythromycin salts, the preparation and the use thereof |
| 01/14/2010 | WO2010003225A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | WO2010003219A1 Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines |
| 01/14/2010 | WO2010003193A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | WO2009098147A3 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids |
| 01/14/2010 | WO2009052090A3 Silicate containing compositions and methods of treatment |
| 01/14/2010 | WO2008133709A3 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 01/14/2010 | US20100010211 Vaccine |
| 01/14/2010 | US20100010210 Vaccine |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010193 Immunogenic complexes and methods relating thereto |
| 01/14/2010 | US20100010018 4-Amino-3-Arylamino-6-Arylpyrazolo[3,4-D) Pyrimidine Derivatives, Methods for their Preparation and their Use as Antiviral Agents |
| 01/14/2010 | US20100010013 Dihydropyrimidine compounds and their uses in manufacture of a medicament for treatment and prevention of viral diseases |
| 01/14/2010 | US20100010011 Compounds that act as a vehicle for delivery through the blood-brain barrier and charge delivery vehicle constructions |
| 01/14/2010 | US20100010008 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009982 Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof |
| 01/14/2010 | US20100009979 Pharmaceuticals containing fluoroquinolones |
| 01/14/2010 | US20100009973 Integrase Inhibitors 3 |
| 01/14/2010 | US20100009959 Pentacyclic Indole Derivatives as Antiviral Agents |
| 01/14/2010 | US20100009957 Novel inhibitors of beta-lactamase |
| 01/14/2010 | US20100009955 Pharmaceutical compositions of cefixime |
| 01/14/2010 | US20100009935 Resistance-repellent retroviral protease inhibitors |
| 01/14/2010 | US20100009925 18-membered macrocycles and analogs thereof |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009009 Method and composition for prevention and treatment of oral fungal infections |
| 01/14/2010 | US20100009008 Bacteriostatic or bacteriocidal compositions and methods |
| 01/14/2010 | US20100008951 Flu vaccine admixture of mannan and flu antigen |
| 01/14/2010 | US20100008948 Recombinant herpesvirus useful in vaccine production |
| 01/14/2010 | US20100008944 Herpes simplex virus mutant and uses therefore |
| 01/14/2010 | US20100008943 Extracellular matrix-binding proteins from staphylococcus aureus |
| 01/14/2010 | US20100008942 Histophilus Somni Polynucleotides, Polypeptides and Methods of Use |
| 01/14/2010 | US20100008941 vaccination directed against the hepatitis C virus (HCV); |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008931 Coronin 1 Modulators for the Treatment of Autoimmune and Lymphoproliferative Disorders and Mycobacterial Infections |
| 01/14/2010 | US20100008925 Methods and compositions for treatment of endotoxin-mediated pro-inflammatory responses |
| 01/14/2010 | US20100008905 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 01/14/2010 | US20100008852 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 01/14/2010 | CA2756053A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and antiviral, antibacterial, and anticancer agents |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | CA2730304A1 Novel compounds, use thereof as medicaments, and method for the preparation thereof |
| 01/14/2010 | CA2730274A1 Use of rifalazil to treat colonic disorders |
| 01/14/2010 | CA2730185A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | CA2729944A1 Antimicrobial composition |
| 01/14/2010 | CA2729852A1 Hydrophobically enhanced aminoglycosides |
| 01/14/2010 | CA2729769A1 Salts of hiv inhibitor compounds |
| 01/14/2010 | CA2729307A1 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 01/14/2010 | CA2728374A1 Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines |
| 01/14/2010 | CA2727820A1 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 01/14/2010 | CA2727651A1 Anti-infective compounds |
| 01/14/2010 | CA2726311A1 Electrostatically charged multi-acting nasal application, product, and method |
| 01/13/2010 | EP2143727A1 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 01/13/2010 | EP2143723A1 Salt of heterocycle-substituted pyridine derivative or crystal thereof |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143436A1 Protein product for treatment of infectious diseases and related inflammatory processes |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2143422A1 Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
| 01/13/2010 | EP2142660A2 Methods and systems for o-glycosylating proteins |
| 01/13/2010 | EP2142568A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/13/2010 | EP2142524A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection |
| 01/13/2010 | EP2142520A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/13/2010 | EP2142192A1 Compositions and kits for treating influenza |
| 01/13/2010 | EP2035385B1 Inhibitors of akt (protein kinase b) |
| 01/13/2010 | EP1499886B1 Methods and compositions for inducing an immune response |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1305322B1 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 01/13/2010 | EP1221968B1 Method of obtaining cellular immune responses from proteins |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101624391A Thiophene derivatives as antiviral agents for flavivirus infection |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100579998C Oral-use polymer and oral-use composition |
| 01/13/2010 | CN100579987C Liver target fusion protein with siRNA guiding effect |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579981C 3,9-dioxaasterane compounds and preparation method and application thereof |
| 01/13/2010 | CN100579980C Ru(II) complex with anticancer liveness and method for preparing the same |
| 01/13/2010 | CN100579977C Method for producing antifungal drug in triazole class |
| 01/13/2010 | CN100579957C Novel arylamidine derivative or salt thereof |
| 01/13/2010 | CN100579580C Mucosal meningococcal vaccines |
| 01/13/2010 | CN100579578C Pyloric spiral bacillus antigen recombinant vaccine |
| 01/13/2010 | CN100579555C Chinese medicine for treating acute appendicitis and preparing method thereof |
| 01/13/2010 | CN100579535C Improvements in or relating to immune functions |
| 01/13/2010 | CN100579532C Florfenicol prodrug having improved water solubility |
| 01/12/2010 | US7645816 Water-soluble compositions of bioactive lipophilic compounds |
| 01/12/2010 | US7645779 Linked biaryl compounds |